Alignment Healthcare (NASDAQ:ALHC) President Sells $618,900.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $20.63, for a total value of $618,900.00. Following the completion of the sale, the president owned 997,015 shares in the company, valued at approximately $20,568,419.45. The trade was a 2.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total value of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The shares were sold at an average price of $18.74, for a total transaction of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total transaction of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.02, for a total transaction of $333,953.62.

Alignment Healthcare Price Performance

Alignment Healthcare stock opened at $20.84 on Friday. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. The stock has a market cap of $4.17 billion, a price-to-earnings ratio of -173.67, a price-to-earnings-growth ratio of 5.23 and a beta of 1.16. The firm has a 50-day moving average of $21.01 and a two-hundred day moving average of $18.26. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas increased its holdings in Alignment Healthcare by 85.8% in the 3rd quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock worth $1,794,000 after buying an additional 47,472 shares during the period. Y Intercept Hong Kong Ltd purchased a new stake in shares of Alignment Healthcare in the 3rd quarter valued at $3,499,000. Inspire Investing LLC purchased a new stake in shares of Alignment Healthcare in the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. increased its stake in shares of Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after acquiring an additional 3,225 shares during the period. Finally, Schroder Investment Management Group raised its holdings in shares of Alignment Healthcare by 28.7% during the second quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock worth $3,437,000 after purchasing an additional 55,314 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ALHC. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. KeyCorp restated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. The Goldman Sachs Group restated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. Barclays increased their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday, October 31st. Finally, Piper Sandler raised their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a research report on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $23.32.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.